Tess O’Meara, MD, MHS, is a hematology/oncology fellow at Dana-Farber Cancer Institute/Mass General Brigham in Boston, MA. She earned her MD and MHS in Computational Biology from Yale School of Medicine in 2020 and completed her Internal Medicine residency at Brigham and Women’s Hospital. Her research at the Broad Institute employs multiomic sequencing and AI methods to uncover biomarkers of resistance and response to novel therapies, with a focus on ADC and IO combinations.
Attending Physician
Medical School
Residency
2020 – 2023
Fellowship